世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
非ステロイド性液体・懸濁液の世界市場成長率 2023-2029Global Non-Sterile Liquids and Suspension Market Growth 2023-2029 世界の非ステロイド性液体および懸濁液の市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。 非滅菌性液体および... もっと見る
サマリー世界の非ステロイド性液体および懸濁液の市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。非滅菌性液体および懸濁液の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。 非滅菌性液体および懸濁液の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 非滅菌性液体および懸濁液のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。 世界の主要な非ステロイド性液体および懸濁液のプレーヤーは、AbbVie Pharmaceutical Contract Manufacturing、Aenova Group、APPCO Pharmaceutical、Atral Pharmaceutical、Aurigene Pharmaceutical Services (Dr. Reddy's), Biological E. Ltd., BioPlus Life Sciences, Bora PharmaceuticalsおよびCambrex Corporationなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。 LPI（エルピーアイ）の最新調査レポート「非滅菌性液体と懸濁液の産業予測」は、過去の売上高に注目し、2022年の世界の非滅菌性液体と懸濁液の総売上高を検証、2023年から2029年の予測非滅菌性液体と懸濁液売上高の地域・市場分野別の総合分析を提供しています。非滅菌性液体およびサスペンションの売上を地域、市場分野、サブセクター別に分類し、世界の非滅菌性液体およびサスペンション産業の詳細な分析を百万米ドル単位で提供します。 本インサイトレポートでは、世界の非滅菌性液体とサスペンションの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、非滅菌性液体および懸濁液のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てた主要グローバル企業の戦略を分析し、加速する世界の非滅菌性液体および懸濁液市場におけるこれらの企業の独自のポジションをより理解することができます。 本インサイトレポートでは、非滅菌性液体および懸濁液の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の非滅菌性液体と懸濁液の現状と将来の軌道について非常にニュアンスのある見方を提供します。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別の非滅菌性液体・懸濁液市場の包括的な概要、市場シェア、および成長機会を紹介します。 市場のセグメンテーション タイプ別セグメンテーション オーラルリキッド ドロップス その他 用途別セグメンテーション ヒト用医薬品 ニュートラシューティカルズ 化粧品 医療機器 動物用医薬品 また、本レポートでは、市場を地域別に分類しています： 米州 アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中近東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報に基づいて選択されており、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析したものである。 AbbVie 医薬品受託製造 アエノバ・グループ APPCOファーマシューティカル アトラル・ファーマシューティカル オーリゲン・ファーマシューティカル・サービス（Dr. Reddy's） バイオロジカル・イー（Biological E. Ltd. バイオプラスライフサイエンス ボラ・ファーマシューティカルズ カンブレックスコーポレーション COCファルマシューティチ コントラクト・ファーマシューティカルズ・リミテッド(CPL) DPTラボラトリーズ ユーロフィンズ JGL d.d. ミカート ファーマビジョン（ヴィジヨン・ホールディング） ピエール・ファーブル トライレックス・ファーマシューティカル・サービス UIファーマシューティカルズ ワスデルグループ アフェナファーマ シンジェン・インターナショナル 本レポートで取り上げる主な質問 世界の非滅菌性液体・懸濁液市場の10年後の展望はどのようなものか？ 世界および地域別に、非滅菌性液体および懸濁液の市場成長を促進する要因は何か？ 市場別、地域別に最も速い成長を遂げる技術は何か？ 非滅菌性液体およびサスペンションの市場機会は、エンドマーケットの規模によってどのように変化するのか？ 非滅菌性液体および懸濁液のタイプ、アプリケーション別内訳は？ COVID-19とロシア・ウクライナ戦争の影響とは？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Non-Sterile Liquids and Suspension Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Non-Sterile Liquids and Suspension by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Non-Sterile Liquids and Suspension by Country/Region, 2018, 2022 & 2029 2.2 Non-Sterile Liquids and Suspension Segment by Type 2.2.1 Oral Liquid 2.2.2 Drops 2.2.3 Other 2.3 Non-Sterile Liquids and Suspension Sales by Type 2.3.1 Global Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) 2.3.2 Global Non-Sterile Liquids and Suspension Revenue and Market Share by Type (2018-2023) 2.3.3 Global Non-Sterile Liquids and Suspension Sale Price by Type (2018-2023) 2.4 Non-Sterile Liquids and Suspension Segment by Application 2.4.1 Human Medication 2.4.2 Nutraceuticals 2.4.3 Cosmetics 2.4.4 Medical Devices 2.4.5 Veterinary Health 2.5 Non-Sterile Liquids and Suspension Sales by Application 2.5.1 Global Non-Sterile Liquids and Suspension Sale Market Share by Application (2018-2023) 2.5.2 Global Non-Sterile Liquids and Suspension Revenue and Market Share by Application (2018-2023) 2.5.3 Global Non-Sterile Liquids and Suspension Sale Price by Application (2018-2023) 3 Global Non-Sterile Liquids and Suspension by Company 3.1 Global Non-Sterile Liquids and Suspension Breakdown Data by Company 3.1.1 Global Non-Sterile Liquids and Suspension Annual Sales by Company (2018-2023) 3.1.2 Global Non-Sterile Liquids and Suspension Sales Market Share by Company (2018-2023) 3.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Company (2018-2023) 3.2.1 Global Non-Sterile Liquids and Suspension Revenue by Company (2018-2023) 3.2.2 Global Non-Sterile Liquids and Suspension Revenue Market Share by Company (2018-2023) 3.3 Global Non-Sterile Liquids and Suspension Sale Price by Company 3.4 Key Manufacturers Non-Sterile Liquids and Suspension Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Non-Sterile Liquids and Suspension Product Location Distribution 3.4.2 Players Non-Sterile Liquids and Suspension Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Non-Sterile Liquids and Suspension by Geographic Region 4.1 World Historic Non-Sterile Liquids and Suspension Market Size by Geographic Region (2018-2023) 4.1.1 Global Non-Sterile Liquids and Suspension Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Non-Sterile Liquids and Suspension Market Size by Country/Region (2018-2023) 4.2.1 Global Non-Sterile Liquids and Suspension Annual Sales by Country/Region (2018-2023) 4.2.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Country/Region (2018-2023) 4.3 Americas Non-Sterile Liquids and Suspension Sales Growth 4.4 APAC Non-Sterile Liquids and Suspension Sales Growth 4.5 Europe Non-Sterile Liquids and Suspension Sales Growth 4.6 Middle East & Africa Non-Sterile Liquids and Suspension Sales Growth 5 Americas 5.1 Americas Non-Sterile Liquids and Suspension Sales by Country 5.1.1 Americas Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 5.1.2 Americas Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 5.2 Americas Non-Sterile Liquids and Suspension Sales by Type 5.3 Americas Non-Sterile Liquids and Suspension Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Non-Sterile Liquids and Suspension Sales by Region 6.1.1 APAC Non-Sterile Liquids and Suspension Sales by Region (2018-2023) 6.1.2 APAC Non-Sterile Liquids and Suspension Revenue by Region (2018-2023) 6.2 APAC Non-Sterile Liquids and Suspension Sales by Type 6.3 APAC Non-Sterile Liquids and Suspension Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Non-Sterile Liquids and Suspension by Country 7.1.1 Europe Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 7.1.2 Europe Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 7.2 Europe Non-Sterile Liquids and Suspension Sales by Type 7.3 Europe Non-Sterile Liquids and Suspension Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Non-Sterile Liquids and Suspension by Country 8.1.1 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 8.1.2 Middle East & Africa Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 8.2 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Type 8.3 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Non-Sterile Liquids and Suspension 10.3 Manufacturing Process Analysis of Non-Sterile Liquids and Suspension 10.4 Industry Chain Structure of Non-Sterile Liquids and Suspension 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Non-Sterile Liquids and Suspension Distributors 11.3 Non-Sterile Liquids and Suspension Customer 12 World Forecast Review for Non-Sterile Liquids and Suspension by Geographic Region 12.1 Global Non-Sterile Liquids and Suspension Market Size Forecast by Region 12.1.1 Global Non-Sterile Liquids and Suspension Forecast by Region (2024-2029) 12.1.2 Global Non-Sterile Liquids and Suspension Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Non-Sterile Liquids and Suspension Forecast by Type 12.7 Global Non-Sterile Liquids and Suspension Forecast by Application 13 Key Players Analysis 13.1 AbbVie Pharmaceutical Contract Manufacturing 13.1.1 AbbVie Pharmaceutical Contract Manufacturing Company Information 13.1.2 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.1.3 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 AbbVie Pharmaceutical Contract Manufacturing Main Business Overview 13.1.5 AbbVie Pharmaceutical Contract Manufacturing Latest Developments 13.2 Aenova Group 13.2.1 Aenova Group Company Information 13.2.2 Aenova Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.2.3 Aenova Group Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Aenova Group Main Business Overview 13.2.5 Aenova Group Latest Developments 13.3 APPCO Pharmaceutical 13.3.1 APPCO Pharmaceutical Company Information 13.3.2 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.3.3 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 APPCO Pharmaceutical Main Business Overview 13.3.5 APPCO Pharmaceutical Latest Developments 13.4 Atral Pharmaceutical 13.4.1 Atral Pharmaceutical Company Information 13.4.2 Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.4.3 Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Atral Pharmaceutical Main Business Overview 13.4.5 Atral Pharmaceutical Latest Developments 13.5 Aurigene Pharmaceutical Services (Dr. Reddy’s) 13.5.1 Aurigene Pharmaceutical Services (Dr. Reddy’s) Company Information 13.5.2 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.5.3 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Aurigene Pharmaceutical Services (Dr. Reddy’s) Main Business Overview 13.5.5 Aurigene Pharmaceutical Services (Dr. Reddy’s) Latest Developments 13.6 Biological E. Ltd. 13.6.1 Biological E. Ltd. Company Information 13.6.2 Biological E. Ltd. Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.6.3 Biological E. Ltd. Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Biological E. Ltd. Main Business Overview 13.6.5 Biological E. Ltd. Latest Developments 13.7 BioPlus Life Sciences 13.7.1 BioPlus Life Sciences Company Information 13.7.2 BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.7.3 BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 BioPlus Life Sciences Main Business Overview 13.7.5 BioPlus Life Sciences Latest Developments 13.8 Bora Pharmaceuticals 13.8.1 Bora Pharmaceuticals Company Information 13.8.2 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.8.3 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bora Pharmaceuticals Main Business Overview 13.8.5 Bora Pharmaceuticals Latest Developments 13.9 Cambrex Corporation 13.9.1 Cambrex Corporation Company Information 13.9.2 Cambrex Corporation Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.9.3 Cambrex Corporation Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Cambrex Corporation Main Business Overview 13.9.5 Cambrex Corporation Latest Developments 13.10 COC Farmaceutici 13.10.1 COC Farmaceutici Company Information 13.10.2 COC Farmaceutici Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.10.3 COC Farmaceutici Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 COC Farmaceutici Main Business Overview 13.10.5 COC Farmaceutici Latest Developments 13.11 Contract Pharmaceuticals Limited (CPL) 13.11.1 Contract Pharmaceuticals Limited (CPL) Company Information 13.11.2 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.11.3 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Contract Pharmaceuticals Limited (CPL) Main Business Overview 13.11.5 Contract Pharmaceuticals Limited (CPL) Latest Developments 13.12 DPT Laboratories 13.12.1 DPT Laboratories Company Information 13.12.2 DPT Laboratories Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.12.3 DPT Laboratories Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 DPT Laboratories Main Business Overview 13.12.5 DPT Laboratories Latest Developments 13.13 Eurofins 13.13.1 Eurofins Company Information 13.13.2 Eurofins Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.13.3 Eurofins Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Eurofins Main Business Overview 13.13.5 Eurofins Latest Developments 13.14 JGL d.d. 13.14.1 JGL d.d. Company Information 13.14.2 JGL d.d. Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.14.3 JGL d.d. Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 JGL d.d. Main Business Overview 13.14.5 JGL d.d. Latest Developments 13.15 Mikart 13.15.1 Mikart Company Information 13.15.2 Mikart Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.15.3 Mikart Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Mikart Main Business Overview 13.15.5 Mikart Latest Developments 13.16 PharmaVision (Vizyon Holding) 13.16.1 PharmaVision (Vizyon Holding) Company Information 13.16.2 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.16.3 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 PharmaVision (Vizyon Holding) Main Business Overview 13.16.5 PharmaVision (Vizyon Holding) Latest Developments 13.17 Pierre Fabre 13.17.1 Pierre Fabre Company Information 13.17.2 Pierre Fabre Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.17.3 Pierre Fabre Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Pierre Fabre Main Business Overview 13.17.5 Pierre Fabre Latest Developments 13.18 TriRx Pharmaceutical Services 13.18.1 TriRx Pharmaceutical Services Company Information 13.18.2 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.18.3 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 TriRx Pharmaceutical Services Main Business Overview 13.18.5 TriRx Pharmaceutical Services Latest Developments 13.19 UI Pharmaceuticals 13.19.1 UI Pharmaceuticals Company Information 13.19.2 UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.19.3 UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 UI Pharmaceuticals Main Business Overview 13.19.5 UI Pharmaceuticals Latest Developments 13.20 Wasdell Group 13.20.1 Wasdell Group Company Information 13.20.2 Wasdell Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.20.3 Wasdell Group Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Wasdell Group Main Business Overview 13.20.5 Wasdell Group Latest Developments 13.21 Aphena Pharma 13.21.1 Aphena Pharma Company Information 13.21.2 Aphena Pharma Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.21.3 Aphena Pharma Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Aphena Pharma Main Business Overview 13.21.5 Aphena Pharma Latest Developments 13.22 Syngene International 13.22.1 Syngene International Company Information 13.22.2 Syngene International Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.22.3 Syngene International Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Syngene International Main Business Overview 13.22.5 Syngene International Latest Developments 14 Research Findings and Conclusion 図表リストList of TablesTable 1. Non-Sterile Liquids and Suspension Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Non-Sterile Liquids and Suspension Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Oral Liquid Table 4. Major Players of Drops Table 5. Major Players of Other Table 6. Global Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 7. Global Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Table 8. Global Non-Sterile Liquids and Suspension Revenue by Type (2018-2023) & ($ million) Table 9. Global Non-Sterile Liquids and Suspension Revenue Market Share by Type (2018-2023) Table 10. Global Non-Sterile Liquids and Suspension Sale Price by Type (2018-2023) & (US$/Unit) Table 11. Global Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 12. Global Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Table 13. Global Non-Sterile Liquids and Suspension Revenue by Application (2018-2023) Table 14. Global Non-Sterile Liquids and Suspension Revenue Market Share by Application (2018-2023) Table 15. Global Non-Sterile Liquids and Suspension Sale Price by Application (2018-2023) & (US$/Unit) Table 16. Global Non-Sterile Liquids and Suspension Sales by Company (2018-2023) & (K Units) Table 17. Global Non-Sterile Liquids and Suspension Sales Market Share by Company (2018-2023) Table 18. Global Non-Sterile Liquids and Suspension Revenue by Company (2018-2023) ($ Millions) Table 19. Global Non-Sterile Liquids and Suspension Revenue Market Share by Company (2018-2023) Table 20. Global Non-Sterile Liquids and Suspension Sale Price by Company (2018-2023) & (US$/Unit) Table 21. Key Manufacturers Non-Sterile Liquids and Suspension Producing Area Distribution and Sales Area Table 22. Players Non-Sterile Liquids and Suspension Products Offered Table 23. Non-Sterile Liquids and Suspension Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Non-Sterile Liquids and Suspension Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Non-Sterile Liquids and Suspension Sales Market Share Geographic Region (2018-2023) Table 28. Global Non-Sterile Liquids and Suspension Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Non-Sterile Liquids and Suspension Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Non-Sterile Liquids and Suspension Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Non-Sterile Liquids and Suspension Sales Market Share by Country/Region (2018-2023) Table 32. Global Non-Sterile Liquids and Suspension Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Non-Sterile Liquids and Suspension Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 35. Americas Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 36. Americas Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 38. Americas Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 39. Americas Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 40. APAC Non-Sterile Liquids and Suspension Sales by Region (2018-2023) & (K Units) Table 41. APAC Non-Sterile Liquids and Suspension Sales Market Share by Region (2018-2023) Table 42. APAC Non-Sterile Liquids and Suspension Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Non-Sterile Liquids and Suspension Revenue Market Share by Region (2018-2023) Table 44. APAC Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 45. APAC Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 46. Europe Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 47. Europe Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 48. Europe Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 50. Europe Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 51. Europe Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Non-Sterile Liquids and Suspension Table 59. Key Market Challenges & Risks of Non-Sterile Liquids and Suspension Table 60. Key Industry Trends of Non-Sterile Liquids and Suspension Table 61. Non-Sterile Liquids and Suspension Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Non-Sterile Liquids and Suspension Distributors List Table 64. Non-Sterile Liquids and Suspension Customer List Table 65. Global Non-Sterile Liquids and Suspension Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Non-Sterile Liquids and Suspension Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Non-Sterile Liquids and Suspension Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Non-Sterile Liquids and Suspension Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Non-Sterile Liquids and Suspension Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Non-Sterile Liquids and Suspension Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Non-Sterile Liquids and Suspension Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Non-Sterile Liquids and Suspension Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. AbbVie Pharmaceutical Contract Manufacturing Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 80. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 81. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 82. AbbVie Pharmaceutical Contract Manufacturing Main Business Table 83. AbbVie Pharmaceutical Contract Manufacturing Latest Developments Table 84. Aenova Group Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 85. Aenova Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 86. Aenova Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. Aenova Group Main Business Table 88. Aenova Group Latest Developments Table 89. APPCO Pharmaceutical Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 90. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 91. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. APPCO Pharmaceutical Main Business Table 93. APPCO Pharmaceutical Latest Developments Table 94. Atral Pharmaceutical Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 95. Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 96. Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Atral Pharmaceutical Main Business Table 98. Atral Pharmaceutical Latest Developments Table 99. Aurigene Pharmaceutical Services (Dr. Reddy’s) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 100. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 101. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Aurigene Pharmaceutical Services (Dr. Reddy’s) Main Business Table 103. Aurigene Pharmaceutical Services (Dr. Reddy’s) Latest Developments Table 104. Biological E. Ltd. Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 105. Biological E. Ltd. Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 106. Biological E. Ltd. Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. Biological E. Ltd. Main Business Table 108. Biological E. Ltd. Latest Developments Table 109. BioPlus Life Sciences Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 110. BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 111. BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. BioPlus Life Sciences Main Business Table 113. BioPlus Life Sciences Latest Developments Table 114. Bora Pharmaceuticals Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 115. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 116. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. Bora Pharmaceuticals Main Business Table 118. Bora Pharmaceuticals Latest Developments Table 119. Cambrex Corporation Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 120. Cambrex Corporation Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 121. Cambrex Corporation Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Cambrex Corporation Main Business Table 123. Cambrex Corporation Latest Developments Table 124. COC Farmaceutici Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 125. COC Farmaceutici Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 126. COC Farmaceutici Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. COC Farmaceutici Main Business Table 128. COC Farmaceutici Latest Developments Table 129. Contract Pharmaceuticals Limited (CPL) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 130. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 131. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. Contract Pharmaceuticals Limited (CPL) Main Business Table 133. Contract Pharmaceuticals Limited (CPL) Latest Developments Table 134. DPT Laboratories Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 135. DPT Laboratories Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 136. DPT Laboratories Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 137. DPT Laboratories Main Business Table 138. DPT Laboratories Latest Developments Table 139. Eurofins Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 140. Eurofins Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 141. Eurofins Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 142. Eurofins Main Business Table 143. Eurofins Latest Developments Table 144. JGL d.d. Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 145. JGL d.d. Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 146. JGL d.d. Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 147. JGL d.d. Main Business Table 148. JGL d.d. Latest Developments Table 149. Mikart Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 150. Mikart Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 151. Mikart Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 152. Mikart Main Business Table 153. Mikart Latest Developments Table 154. PharmaVision (Vizyon Holding) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 155. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 156. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 157. PharmaVision (Vizyon Holding) Main Business Table 158. PharmaVision (Vizyon Holding) Latest Developments Table 159. Pierre Fabre Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 160. Pierre Fabre Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 161. Pierre Fabre Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 162. Pierre Fabre Main Business Table 163. Pierre Fabre Latest Developments Table 164. TriRx Pharmaceutical Services Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 165. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 166. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 167. TriRx Pharmaceutical Services Main Business Table 168. TriRx Pharmaceutical Services Latest Developments Table 169. UI Pharmaceuticals Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 170. UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 171. UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 172. UI Pharmaceuticals Main Business Table 173. UI Pharmaceuticals Latest Developments Table 174. Wasdell Group Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 175. Wasdell Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 176. Wasdell Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 177. Wasdell Group Main Business Table 178. Wasdell Group Latest Developments Table 179. Aphena Pharma Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 180. Aphena Pharma Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 181. Aphena Pharma Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 182. Aphena Pharma Main Business Table 183. Aphena Pharma Latest Developments Table 184. Syngene International Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 185. Syngene International Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 186. Syngene International Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 187. Syngene International Main Business Table 188. Syngene International Latest Developments List of Figures Figure 1. Picture of Non-Sterile Liquids and Suspension Figure 2. Non-Sterile Liquids and Suspension Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Non-Sterile Liquids and Suspension Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Non-Sterile Liquids and Suspension Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Non-Sterile Liquids and Suspension Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Oral Liquid Figure 10. Product Picture of Drops Figure 11. Product Picture of Other Figure 12. Global Non-Sterile Liquids and Suspension Sales Market Share by Type in 2022 Figure 13. Global Non-Sterile Liquids and Suspension Revenue Market Share by Type (2018-2023) Figure 14. Non-Sterile Liquids and Suspension Consumed in Human Medication Figure 15. Global Non-Sterile Liquids and Suspension Market: Human Medication (2018-2023) & (K Units) Figure 16. Non-Sterile Liquids and Suspension Consumed in Nutraceuticals Figure 17. Global Non-Sterile Liquids and Suspension Market: Nutraceuticals (2018-2023) & (K Units) Figure 18. Non-Sterile Liquids and Suspension Consumed in Cosmetics Figure 19. Global Non-Sterile Liquids and Suspension Market: Cosmetics (2018-2023) & (K Units) Figure 20. Non-Sterile Liquids and Suspension Consumed in Medical Devices Figure 21. Global Non-Sterile Liquids and Suspension Market: Medical Devices (2018-2023) & (K Units) Figure 22. Non-Sterile Liquids and Suspension Consumed in Veterinary Health Figure 23. Global Non-Sterile Liquids and Suspension Market: Veterinary Health (2018-2023) & (K Units) Figure 24. Global Non-Sterile Liquids and Suspension Sales Market Share by Application (2022) Figure 25. Global Non-Sterile Liquids and Suspension Revenue Market Share by Application in 2022 Figure 26. Non-Sterile Liquids and Suspension Sales Market by Company in 2022 (K Units) Figure 27. Global Non-Sterile Liquids and Suspension Sales Market Share by Company in 2022 Figure 28. Non-Sterile Liquids and Suspension Revenue Market by Company in 2022 ($ Million) Figure 29. Global Non-Sterile Liquids and Suspension Revenue Market Share by Company in 2022 Figure 30. Global Non-Sterile Liquids and Suspension Sales Market Share by Geographic Region (2018-2023) Figure 31. Global Non-Sterile Liquids and Suspension Revenue Market Share by Geographic Region in 2022 Figure 32. Americas Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 33. Americas Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 34. APAC Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 35. APAC Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 36. Europe Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 37. Europe Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 38. Middle East & Africa Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 39. Middle East & Africa Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 40. Americas Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 41. Americas Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 42. Americas Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 43. Americas Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 44. United States Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 45. Canada Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 46. Mexico Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 47. Brazil Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 48. APAC Non-Sterile Liquids and Suspension Sales Market Share by Region in 2022 Figure 49. APAC Non-Sterile Liquids and Suspension Revenue Market Share by Regions in 2022 Figure 50. APAC Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 51. APAC Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 52. China Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 53. Japan Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 54. South Korea Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 55. Southeast Asia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 56. India Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 57. Australia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 58. China Taiwan Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 59. Europe Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 60. Europe Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 61. Europe Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 62. Europe Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 63. Germany Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 64. France Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 65. UK Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 66. Italy Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 67. Russia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 68. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 69. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 70. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 71. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 72. Egypt Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 73. South Africa Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 74. Israel Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 75. Turkey Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 76. GCC Country Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of Non-Sterile Liquids and Suspension in 2022 Figure 78. Manufacturing Process Analysis of Non-Sterile Liquids and Suspension Figure 79. Industry Chain Structure of Non-Sterile Liquids and Suspension Figure 80. Channels of Distribution Figure 81. Global Non-Sterile Liquids and Suspension Sales Market Forecast by Region (2024-2029) Figure 82. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Region (2024-2029) Figure 83. Global Non-Sterile Liquids and Suspension Sales Market Share Forecast by Type (2024-2029) Figure 84. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Type (2024-2029) Figure 85. Global Non-Sterile Liquids and Suspension Sales Market Share Forecast by Application (2024-2029) Figure 86. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Application (2024-2029)
SummaryThe global Non-Sterile Liquids and Suspension market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Non-Sterile Liquids and Suspension Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Non-Sterile Liquids and Suspension by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Non-Sterile Liquids and Suspension by Country/Region, 2018, 2022 & 2029 2.2 Non-Sterile Liquids and Suspension Segment by Type 2.2.1 Oral Liquid 2.2.2 Drops 2.2.3 Other 2.3 Non-Sterile Liquids and Suspension Sales by Type 2.3.1 Global Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) 2.3.2 Global Non-Sterile Liquids and Suspension Revenue and Market Share by Type (2018-2023) 2.3.3 Global Non-Sterile Liquids and Suspension Sale Price by Type (2018-2023) 2.4 Non-Sterile Liquids and Suspension Segment by Application 2.4.1 Human Medication 2.4.2 Nutraceuticals 2.4.3 Cosmetics 2.4.4 Medical Devices 2.4.5 Veterinary Health 2.5 Non-Sterile Liquids and Suspension Sales by Application 2.5.1 Global Non-Sterile Liquids and Suspension Sale Market Share by Application (2018-2023) 2.5.2 Global Non-Sterile Liquids and Suspension Revenue and Market Share by Application (2018-2023) 2.5.3 Global Non-Sterile Liquids and Suspension Sale Price by Application (2018-2023) 3 Global Non-Sterile Liquids and Suspension by Company 3.1 Global Non-Sterile Liquids and Suspension Breakdown Data by Company 3.1.1 Global Non-Sterile Liquids and Suspension Annual Sales by Company (2018-2023) 3.1.2 Global Non-Sterile Liquids and Suspension Sales Market Share by Company (2018-2023) 3.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Company (2018-2023) 3.2.1 Global Non-Sterile Liquids and Suspension Revenue by Company (2018-2023) 3.2.2 Global Non-Sterile Liquids and Suspension Revenue Market Share by Company (2018-2023) 3.3 Global Non-Sterile Liquids and Suspension Sale Price by Company 3.4 Key Manufacturers Non-Sterile Liquids and Suspension Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Non-Sterile Liquids and Suspension Product Location Distribution 3.4.2 Players Non-Sterile Liquids and Suspension Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Non-Sterile Liquids and Suspension by Geographic Region 4.1 World Historic Non-Sterile Liquids and Suspension Market Size by Geographic Region (2018-2023) 4.1.1 Global Non-Sterile Liquids and Suspension Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Non-Sterile Liquids and Suspension Market Size by Country/Region (2018-2023) 4.2.1 Global Non-Sterile Liquids and Suspension Annual Sales by Country/Region (2018-2023) 4.2.2 Global Non-Sterile Liquids and Suspension Annual Revenue by Country/Region (2018-2023) 4.3 Americas Non-Sterile Liquids and Suspension Sales Growth 4.4 APAC Non-Sterile Liquids and Suspension Sales Growth 4.5 Europe Non-Sterile Liquids and Suspension Sales Growth 4.6 Middle East & Africa Non-Sterile Liquids and Suspension Sales Growth 5 Americas 5.1 Americas Non-Sterile Liquids and Suspension Sales by Country 5.1.1 Americas Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 5.1.2 Americas Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 5.2 Americas Non-Sterile Liquids and Suspension Sales by Type 5.3 Americas Non-Sterile Liquids and Suspension Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Non-Sterile Liquids and Suspension Sales by Region 6.1.1 APAC Non-Sterile Liquids and Suspension Sales by Region (2018-2023) 6.1.2 APAC Non-Sterile Liquids and Suspension Revenue by Region (2018-2023) 6.2 APAC Non-Sterile Liquids and Suspension Sales by Type 6.3 APAC Non-Sterile Liquids and Suspension Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Non-Sterile Liquids and Suspension by Country 7.1.1 Europe Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 7.1.2 Europe Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 7.2 Europe Non-Sterile Liquids and Suspension Sales by Type 7.3 Europe Non-Sterile Liquids and Suspension Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Non-Sterile Liquids and Suspension by Country 8.1.1 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Country (2018-2023) 8.1.2 Middle East & Africa Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) 8.2 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Type 8.3 Middle East & Africa Non-Sterile Liquids and Suspension Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Non-Sterile Liquids and Suspension 10.3 Manufacturing Process Analysis of Non-Sterile Liquids and Suspension 10.4 Industry Chain Structure of Non-Sterile Liquids and Suspension 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Non-Sterile Liquids and Suspension Distributors 11.3 Non-Sterile Liquids and Suspension Customer 12 World Forecast Review for Non-Sterile Liquids and Suspension by Geographic Region 12.1 Global Non-Sterile Liquids and Suspension Market Size Forecast by Region 12.1.1 Global Non-Sterile Liquids and Suspension Forecast by Region (2024-2029) 12.1.2 Global Non-Sterile Liquids and Suspension Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Non-Sterile Liquids and Suspension Forecast by Type 12.7 Global Non-Sterile Liquids and Suspension Forecast by Application 13 Key Players Analysis 13.1 AbbVie Pharmaceutical Contract Manufacturing 13.1.1 AbbVie Pharmaceutical Contract Manufacturing Company Information 13.1.2 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.1.3 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 AbbVie Pharmaceutical Contract Manufacturing Main Business Overview 13.1.5 AbbVie Pharmaceutical Contract Manufacturing Latest Developments 13.2 Aenova Group 13.2.1 Aenova Group Company Information 13.2.2 Aenova Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.2.3 Aenova Group Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Aenova Group Main Business Overview 13.2.5 Aenova Group Latest Developments 13.3 APPCO Pharmaceutical 13.3.1 APPCO Pharmaceutical Company Information 13.3.2 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.3.3 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 APPCO Pharmaceutical Main Business Overview 13.3.5 APPCO Pharmaceutical Latest Developments 13.4 Atral Pharmaceutical 13.4.1 Atral Pharmaceutical Company Information 13.4.2 Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.4.3 Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Atral Pharmaceutical Main Business Overview 13.4.5 Atral Pharmaceutical Latest Developments 13.5 Aurigene Pharmaceutical Services (Dr. Reddy’s) 13.5.1 Aurigene Pharmaceutical Services (Dr. Reddy’s) Company Information 13.5.2 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.5.3 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Aurigene Pharmaceutical Services (Dr. Reddy’s) Main Business Overview 13.5.5 Aurigene Pharmaceutical Services (Dr. Reddy’s) Latest Developments 13.6 Biological E. Ltd. 13.6.1 Biological E. Ltd. Company Information 13.6.2 Biological E. Ltd. Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.6.3 Biological E. Ltd. Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Biological E. Ltd. Main Business Overview 13.6.5 Biological E. Ltd. Latest Developments 13.7 BioPlus Life Sciences 13.7.1 BioPlus Life Sciences Company Information 13.7.2 BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.7.3 BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 BioPlus Life Sciences Main Business Overview 13.7.5 BioPlus Life Sciences Latest Developments 13.8 Bora Pharmaceuticals 13.8.1 Bora Pharmaceuticals Company Information 13.8.2 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.8.3 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bora Pharmaceuticals Main Business Overview 13.8.5 Bora Pharmaceuticals Latest Developments 13.9 Cambrex Corporation 13.9.1 Cambrex Corporation Company Information 13.9.2 Cambrex Corporation Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.9.3 Cambrex Corporation Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Cambrex Corporation Main Business Overview 13.9.5 Cambrex Corporation Latest Developments 13.10 COC Farmaceutici 13.10.1 COC Farmaceutici Company Information 13.10.2 COC Farmaceutici Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.10.3 COC Farmaceutici Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 COC Farmaceutici Main Business Overview 13.10.5 COC Farmaceutici Latest Developments 13.11 Contract Pharmaceuticals Limited (CPL) 13.11.1 Contract Pharmaceuticals Limited (CPL) Company Information 13.11.2 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.11.3 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Contract Pharmaceuticals Limited (CPL) Main Business Overview 13.11.5 Contract Pharmaceuticals Limited (CPL) Latest Developments 13.12 DPT Laboratories 13.12.1 DPT Laboratories Company Information 13.12.2 DPT Laboratories Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.12.3 DPT Laboratories Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 DPT Laboratories Main Business Overview 13.12.5 DPT Laboratories Latest Developments 13.13 Eurofins 13.13.1 Eurofins Company Information 13.13.2 Eurofins Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.13.3 Eurofins Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Eurofins Main Business Overview 13.13.5 Eurofins Latest Developments 13.14 JGL d.d. 13.14.1 JGL d.d. Company Information 13.14.2 JGL d.d. Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.14.3 JGL d.d. Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 JGL d.d. Main Business Overview 13.14.5 JGL d.d. Latest Developments 13.15 Mikart 13.15.1 Mikart Company Information 13.15.2 Mikart Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.15.3 Mikart Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Mikart Main Business Overview 13.15.5 Mikart Latest Developments 13.16 PharmaVision (Vizyon Holding) 13.16.1 PharmaVision (Vizyon Holding) Company Information 13.16.2 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.16.3 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 PharmaVision (Vizyon Holding) Main Business Overview 13.16.5 PharmaVision (Vizyon Holding) Latest Developments 13.17 Pierre Fabre 13.17.1 Pierre Fabre Company Information 13.17.2 Pierre Fabre Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.17.3 Pierre Fabre Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Pierre Fabre Main Business Overview 13.17.5 Pierre Fabre Latest Developments 13.18 TriRx Pharmaceutical Services 13.18.1 TriRx Pharmaceutical Services Company Information 13.18.2 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.18.3 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 TriRx Pharmaceutical Services Main Business Overview 13.18.5 TriRx Pharmaceutical Services Latest Developments 13.19 UI Pharmaceuticals 13.19.1 UI Pharmaceuticals Company Information 13.19.2 UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.19.3 UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 UI Pharmaceuticals Main Business Overview 13.19.5 UI Pharmaceuticals Latest Developments 13.20 Wasdell Group 13.20.1 Wasdell Group Company Information 13.20.2 Wasdell Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.20.3 Wasdell Group Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Wasdell Group Main Business Overview 13.20.5 Wasdell Group Latest Developments 13.21 Aphena Pharma 13.21.1 Aphena Pharma Company Information 13.21.2 Aphena Pharma Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.21.3 Aphena Pharma Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Aphena Pharma Main Business Overview 13.21.5 Aphena Pharma Latest Developments 13.22 Syngene International 13.22.1 Syngene International Company Information 13.22.2 Syngene International Non-Sterile Liquids and Suspension Product Portfolios and Specifications 13.22.3 Syngene International Non-Sterile Liquids and Suspension Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Syngene International Main Business Overview 13.22.5 Syngene International Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Non-Sterile Liquids and Suspension Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Non-Sterile Liquids and Suspension Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Oral Liquid Table 4. Major Players of Drops Table 5. Major Players of Other Table 6. Global Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 7. Global Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Table 8. Global Non-Sterile Liquids and Suspension Revenue by Type (2018-2023) & ($ million) Table 9. Global Non-Sterile Liquids and Suspension Revenue Market Share by Type (2018-2023) Table 10. Global Non-Sterile Liquids and Suspension Sale Price by Type (2018-2023) & (US$/Unit) Table 11. Global Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 12. Global Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Table 13. Global Non-Sterile Liquids and Suspension Revenue by Application (2018-2023) Table 14. Global Non-Sterile Liquids and Suspension Revenue Market Share by Application (2018-2023) Table 15. Global Non-Sterile Liquids and Suspension Sale Price by Application (2018-2023) & (US$/Unit) Table 16. Global Non-Sterile Liquids and Suspension Sales by Company (2018-2023) & (K Units) Table 17. Global Non-Sterile Liquids and Suspension Sales Market Share by Company (2018-2023) Table 18. Global Non-Sterile Liquids and Suspension Revenue by Company (2018-2023) ($ Millions) Table 19. Global Non-Sterile Liquids and Suspension Revenue Market Share by Company (2018-2023) Table 20. Global Non-Sterile Liquids and Suspension Sale Price by Company (2018-2023) & (US$/Unit) Table 21. Key Manufacturers Non-Sterile Liquids and Suspension Producing Area Distribution and Sales Area Table 22. Players Non-Sterile Liquids and Suspension Products Offered Table 23. Non-Sterile Liquids and Suspension Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Non-Sterile Liquids and Suspension Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Non-Sterile Liquids and Suspension Sales Market Share Geographic Region (2018-2023) Table 28. Global Non-Sterile Liquids and Suspension Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Non-Sterile Liquids and Suspension Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Non-Sterile Liquids and Suspension Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Non-Sterile Liquids and Suspension Sales Market Share by Country/Region (2018-2023) Table 32. Global Non-Sterile Liquids and Suspension Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Non-Sterile Liquids and Suspension Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 35. Americas Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 36. Americas Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 38. Americas Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 39. Americas Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 40. APAC Non-Sterile Liquids and Suspension Sales by Region (2018-2023) & (K Units) Table 41. APAC Non-Sterile Liquids and Suspension Sales Market Share by Region (2018-2023) Table 42. APAC Non-Sterile Liquids and Suspension Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Non-Sterile Liquids and Suspension Revenue Market Share by Region (2018-2023) Table 44. APAC Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 45. APAC Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 46. Europe Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 47. Europe Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 48. Europe Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 50. Europe Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 51. Europe Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Non-Sterile Liquids and Suspension Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Non-Sterile Liquids and Suspension Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Non-Sterile Liquids and Suspension Table 59. Key Market Challenges & Risks of Non-Sterile Liquids and Suspension Table 60. Key Industry Trends of Non-Sterile Liquids and Suspension Table 61. Non-Sterile Liquids and Suspension Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Non-Sterile Liquids and Suspension Distributors List Table 64. Non-Sterile Liquids and Suspension Customer List Table 65. Global Non-Sterile Liquids and Suspension Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Non-Sterile Liquids and Suspension Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Non-Sterile Liquids and Suspension Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Non-Sterile Liquids and Suspension Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Non-Sterile Liquids and Suspension Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Non-Sterile Liquids and Suspension Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Non-Sterile Liquids and Suspension Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Non-Sterile Liquids and Suspension Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Non-Sterile Liquids and Suspension Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. AbbVie Pharmaceutical Contract Manufacturing Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 80. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 81. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 82. AbbVie Pharmaceutical Contract Manufacturing Main Business Table 83. AbbVie Pharmaceutical Contract Manufacturing Latest Developments Table 84. Aenova Group Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 85. Aenova Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 86. Aenova Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. Aenova Group Main Business Table 88. Aenova Group Latest Developments Table 89. APPCO Pharmaceutical Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 90. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 91. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. APPCO Pharmaceutical Main Business Table 93. APPCO Pharmaceutical Latest Developments Table 94. Atral Pharmaceutical Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 95. Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 96. Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Atral Pharmaceutical Main Business Table 98. Atral Pharmaceutical Latest Developments Table 99. Aurigene Pharmaceutical Services (Dr. Reddy’s) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 100. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 101. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Aurigene Pharmaceutical Services (Dr. Reddy’s) Main Business Table 103. Aurigene Pharmaceutical Services (Dr. Reddy’s) Latest Developments Table 104. Biological E. Ltd. Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 105. Biological E. Ltd. Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 106. Biological E. Ltd. Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. Biological E. Ltd. Main Business Table 108. Biological E. Ltd. Latest Developments Table 109. BioPlus Life Sciences Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 110. BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 111. BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. BioPlus Life Sciences Main Business Table 113. BioPlus Life Sciences Latest Developments Table 114. Bora Pharmaceuticals Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 115. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 116. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. Bora Pharmaceuticals Main Business Table 118. Bora Pharmaceuticals Latest Developments Table 119. Cambrex Corporation Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 120. Cambrex Corporation Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 121. Cambrex Corporation Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Cambrex Corporation Main Business Table 123. Cambrex Corporation Latest Developments Table 124. COC Farmaceutici Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 125. COC Farmaceutici Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 126. COC Farmaceutici Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. COC Farmaceutici Main Business Table 128. COC Farmaceutici Latest Developments Table 129. Contract Pharmaceuticals Limited (CPL) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 130. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 131. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. Contract Pharmaceuticals Limited (CPL) Main Business Table 133. Contract Pharmaceuticals Limited (CPL) Latest Developments Table 134. DPT Laboratories Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 135. DPT Laboratories Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 136. DPT Laboratories Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 137. DPT Laboratories Main Business Table 138. DPT Laboratories Latest Developments Table 139. Eurofins Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 140. Eurofins Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 141. Eurofins Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 142. Eurofins Main Business Table 143. Eurofins Latest Developments Table 144. JGL d.d. Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 145. JGL d.d. Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 146. JGL d.d. Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 147. JGL d.d. Main Business Table 148. JGL d.d. Latest Developments Table 149. Mikart Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 150. Mikart Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 151. Mikart Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 152. Mikart Main Business Table 153. Mikart Latest Developments Table 154. PharmaVision (Vizyon Holding) Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 155. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 156. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 157. PharmaVision (Vizyon Holding) Main Business Table 158. PharmaVision (Vizyon Holding) Latest Developments Table 159. Pierre Fabre Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 160. Pierre Fabre Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 161. Pierre Fabre Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 162. Pierre Fabre Main Business Table 163. Pierre Fabre Latest Developments Table 164. TriRx Pharmaceutical Services Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 165. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 166. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 167. TriRx Pharmaceutical Services Main Business Table 168. TriRx Pharmaceutical Services Latest Developments Table 169. UI Pharmaceuticals Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 170. UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 171. UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 172. UI Pharmaceuticals Main Business Table 173. UI Pharmaceuticals Latest Developments Table 174. Wasdell Group Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 175. Wasdell Group Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 176. Wasdell Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 177. Wasdell Group Main Business Table 178. Wasdell Group Latest Developments Table 179. Aphena Pharma Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 180. Aphena Pharma Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 181. Aphena Pharma Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 182. Aphena Pharma Main Business Table 183. Aphena Pharma Latest Developments Table 184. Syngene International Basic Information, Non-Sterile Liquids and Suspension Manufacturing Base, Sales Area and Its Competitors Table 185. Syngene International Non-Sterile Liquids and Suspension Product Portfolios and Specifications Table 186. Syngene International Non-Sterile Liquids and Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 187. Syngene International Main Business Table 188. Syngene International Latest Developments List of Figures Figure 1. Picture of Non-Sterile Liquids and Suspension Figure 2. Non-Sterile Liquids and Suspension Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Non-Sterile Liquids and Suspension Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Non-Sterile Liquids and Suspension Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Non-Sterile Liquids and Suspension Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Oral Liquid Figure 10. Product Picture of Drops Figure 11. Product Picture of Other Figure 12. Global Non-Sterile Liquids and Suspension Sales Market Share by Type in 2022 Figure 13. Global Non-Sterile Liquids and Suspension Revenue Market Share by Type (2018-2023) Figure 14. Non-Sterile Liquids and Suspension Consumed in Human Medication Figure 15. Global Non-Sterile Liquids and Suspension Market: Human Medication (2018-2023) & (K Units) Figure 16. Non-Sterile Liquids and Suspension Consumed in Nutraceuticals Figure 17. Global Non-Sterile Liquids and Suspension Market: Nutraceuticals (2018-2023) & (K Units) Figure 18. Non-Sterile Liquids and Suspension Consumed in Cosmetics Figure 19. Global Non-Sterile Liquids and Suspension Market: Cosmetics (2018-2023) & (K Units) Figure 20. Non-Sterile Liquids and Suspension Consumed in Medical Devices Figure 21. Global Non-Sterile Liquids and Suspension Market: Medical Devices (2018-2023) & (K Units) Figure 22. Non-Sterile Liquids and Suspension Consumed in Veterinary Health Figure 23. Global Non-Sterile Liquids and Suspension Market: Veterinary Health (2018-2023) & (K Units) Figure 24. Global Non-Sterile Liquids and Suspension Sales Market Share by Application (2022) Figure 25. Global Non-Sterile Liquids and Suspension Revenue Market Share by Application in 2022 Figure 26. Non-Sterile Liquids and Suspension Sales Market by Company in 2022 (K Units) Figure 27. Global Non-Sterile Liquids and Suspension Sales Market Share by Company in 2022 Figure 28. Non-Sterile Liquids and Suspension Revenue Market by Company in 2022 ($ Million) Figure 29. Global Non-Sterile Liquids and Suspension Revenue Market Share by Company in 2022 Figure 30. Global Non-Sterile Liquids and Suspension Sales Market Share by Geographic Region (2018-2023) Figure 31. Global Non-Sterile Liquids and Suspension Revenue Market Share by Geographic Region in 2022 Figure 32. Americas Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 33. Americas Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 34. APAC Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 35. APAC Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 36. Europe Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 37. Europe Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 38. Middle East & Africa Non-Sterile Liquids and Suspension Sales 2018-2023 (K Units) Figure 39. Middle East & Africa Non-Sterile Liquids and Suspension Revenue 2018-2023 ($ Millions) Figure 40. Americas Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 41. Americas Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 42. Americas Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 43. Americas Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 44. United States Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 45. Canada Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 46. Mexico Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 47. Brazil Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 48. APAC Non-Sterile Liquids and Suspension Sales Market Share by Region in 2022 Figure 49. APAC Non-Sterile Liquids and Suspension Revenue Market Share by Regions in 2022 Figure 50. APAC Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 51. APAC Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 52. China Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 53. Japan Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 54. South Korea Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 55. Southeast Asia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 56. India Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 57. Australia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 58. China Taiwan Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 59. Europe Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 60. Europe Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 61. Europe Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 62. Europe Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 63. Germany Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 64. France Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 65. UK Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 66. Italy Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 67. Russia Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 68. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Country in 2022 Figure 69. Middle East & Africa Non-Sterile Liquids and Suspension Revenue Market Share by Country in 2022 Figure 70. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Type (2018-2023) Figure 71. Middle East & Africa Non-Sterile Liquids and Suspension Sales Market Share by Application (2018-2023) Figure 72. Egypt Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 73. South Africa Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 74. Israel Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 75. Turkey Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 76. GCC Country Non-Sterile Liquids and Suspension Revenue Growth 2018-2023 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of Non-Sterile Liquids and Suspension in 2022 Figure 78. Manufacturing Process Analysis of Non-Sterile Liquids and Suspension Figure 79. Industry Chain Structure of Non-Sterile Liquids and Suspension Figure 80. Channels of Distribution Figure 81. Global Non-Sterile Liquids and Suspension Sales Market Forecast by Region (2024-2029) Figure 82. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Region (2024-2029) Figure 83. Global Non-Sterile Liquids and Suspension Sales Market Share Forecast by Type (2024-2029) Figure 84. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Type (2024-2029) Figure 85. Global Non-Sterile Liquids and Suspension Sales Market Share Forecast by Application (2024-2029) Figure 86. Global Non-Sterile Liquids and Suspension Revenue Market Share Forecast by Application (2024-2029)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（suspension）の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |
